Cellegy Pharmaceuticals

therapeutics targeting gastroenterology conditions and sexual dysfunction using topical formulations and nitric oxide donor technologies

History:

Cellegy Pharmaceuticals has sold off most of its assets and is set to be acquired by Adamis (Feb 2008)

Acquisitions:
Biosyn (2004)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northern California

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: